scholarly article | Q13442814 |
P2093 | author name string | Chun Il Kim | |
Mi Sun Choi | |||
Byung Hoon Kim | |||
Choal Hee Park | |||
Hyea Ra Jung | |||
Hyuk Soo Chang | |||
Seok Jin Jung | |||
P2860 | cites work | Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone | Q60504419 |
Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma | Q63247804 | ||
Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin | Q69520475 | ||
Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow | Q73406513 | ||
T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer | Q73847638 | ||
Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells | Q78710357 | ||
Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer | Q80506644 | ||
Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix | Q81428298 | ||
Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression | Q83187267 | ||
Involvement of chemokine receptors in breast cancer metastasis | Q24290909 | ||
Actin-based cell motility and cell locomotion | Q28276582 | ||
CXCR4 regulates growth of both primary and metastatic breast cancer | Q28296113 | ||
Chemokines: a new classification system and their role in immunity | Q29615663 | ||
Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer | Q33868710 | ||
The role of chemokines in melanoma tumor growth and metastasis | Q34680888 | ||
Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100. | Q36264524 | ||
A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. | Q37089440 | ||
Metabolomics: a novel approach to early and noninvasive prostate cancer detection. | Q37850315 | ||
Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis | Q40538377 | ||
A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma | Q40543358 | ||
Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. | Q40583095 | ||
Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells | Q40692637 | ||
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer | Q40696855 | ||
Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer | Q47272097 | ||
Transendothelial migration and trafficking of leukocytes in LFA-1-deficient mice | Q47915830 | ||
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome | Q47917544 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 607-611 | |
P577 | publication date | 2011-09-28 | |
P1433 | published in | Korean Journal of Urology | Q26842099 |
P1476 | title | Correlation between Chemokine Receptor CXCR4 Expression and Prognostic Factors in Patients with Prostate Cancer | |
P478 | volume | 52 |
Q48045458 | Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention. |
Q59104388 | CXCR4 Expression in Gastric Cancer and Bone Marrow: Association with Hypoxia-Regulated Indices, Disseminated Tumor Cells, and Patients Survival |
Q45122565 | CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers |
Q28084663 | CXCR4 over-expression and survival in cancer: a system review and meta-analysis |
Q60931267 | Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization |
Q86814803 | Chemokines in tumor progression and metastasis |
Q34451400 | Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy |
Q37359760 | Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome |
Q37225329 | Emerging targets in cancer management: role of the CXCL12/CXCR4 axis |
Q39402696 | Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4. |
Q95924579 | Evaluation of Somatostatin and CXCR4 Receptor Expression in a Large Set of Prostate Cancer Samples Using Tissue Microarrays and Well-Characterized Monoclonal Antibodies |
Q40449073 | Expression of CXC chemokine receptor-4 and forkhead box 3 in neuroblastoma cells and response to chemotherapy. |
Q89998115 | Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling |
Q33555276 | High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma |
Q28393898 | Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells |
Q41550917 | Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer. |
Q37116576 | PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling |
Q39424549 | Prostate Cancer Stem Cell Markers Drive Progression, Therapeutic Resistance, and Bone Metastasis |
Q35213463 | Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis |
Q26785506 | The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review |
Q39013775 | The influence of lentivirus-mediated CXCR4 RNA interference on hepatic metastasis of colorectal cancer |
Q34927102 | Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer |
Q35195342 | miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer |
Search more.